Gossamer Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	38.46	47.61	45.78	49.73	39.14	44.05	0.26	0.08
Research & Development	135.3	170.92	170.27	160.85	143.4	55.28	0.89	0
Other Operating Expenses	10	0.07	0.08	23.38	3.6	49.66	5.5	0
Operating Expenses	183.76	218.59	216.12	233.96	186.14	148.99	6.65	0.08
Operating Income	-183.76	-218.59	-216.12	-233.96	-186.14	-148.99	-6.65	-0.08
Interest Expense / Income	13.51	13.88	19.44	12.67	1.94	0.01	0	0
Other Expense / Income	-17.45	-3.1	-1.56	-3.27	-7.77	-2.04	0.12	-
Pretax Income	-179.82	-229.38	-234	-243.36	-180.31	-146.97	-6.77	-0.08
Net Income	-179.82	-229.38	-234	-243.36	-180.31	-146.97	-6.77	-0.08
Shares Outstanding (Basic)	153	85	75	69	55	7	9	9
Shares Outstanding (Diluted)	153	85	75	69	55	7	9	9
Shares Change	80.46%	13.00%	9.24%	25.16%	741.53%	-28.99%	-	-
EPS (Basic)	-1.18	-2.71	-3.13	-3.55	-3.29	-22.59	-0.74	-0.01
EPS (Diluted)	-1.18	-2.71	-3.13	-3.55	-3.29	-22.59	-0.74	-0.01
Free Cash Flow	-159.16	-187.44	-190.44	-177.86	-147.8	-54.53	-5.75	0.02
Free Cash Flow Per Share	-1.04	-2.22	-2.54	-2.60	-2.70	-8.38	-0.63	0.00
EBITDA	-161.92	-211.07	-209.4	-226.43	-175.28	-146.66	-6.77	-0.08
Depreciation & Amortization	4.39	4.43	5.17	4.27	3.09	0.3	0	0
EBIT	-166.31	-215.5	-214.56	-230.69	-178.37	-146.96	-6.77	-0.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).